About: A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1984

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1984 (uk) article scientifique publié en 1984 (fr) im Dezember 1984 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 December 1984 (en) artículu científicu espublizáu n'avientu de 1984 (ast)
publication date	wds:Q70409082-E7E5C9B6-EA03-4763-A4A4-492F759EE8E0
publication date	1984-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70409082-417543C8-8AF3-443B-B191-B2450D629E36
language of work or name	English
author name string	wds:Q70409082-0033CFE2-59C1-47B2-B214-CE3479F07BCB wds:Q70409082-43D65551-B45A-45A7-8C5B-F908AD5220B8 wds:Q70409082-C9389101-4B03-4F4B-8080-5F344A916C31 wds:Q70409082-D90B71B6-429A-4F5D-8985-6902EF3083F3 wds:Q70409082-F4B23D35-2794-40D3-A102-E28A0C47BCE9
author name string	Watts C Russell AS Esdaile J Edelman J Thompson RN
rdfs:label	A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis (en) A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis (nl)
skos:prefLabel	A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis (en) A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis (nl)
name	A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis (en) A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis (nl)
title	wds:Q70409082-DE5059D9-1311-4F14-8C86-ADA1B612460C
title	A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis (en)
page(s)	wds:Q70409082-236D8E9E-F282-4242-A05D-B306C3E8E1C0
page(s)	760-763
instance of	wds:Q70409082-FD1372B3-EA50-4ED8-A455-F27573E607B1
instance of	scholarly article
main subject	wds:Q70409082-2C1666E4-EB5D-48CF-8EC8-C81DD98971D8 wds:Q70409082-BC9A3803-073A-4556-8680-B6458F35B981
main subject	rheumatoid arthritis wd:Q422232
PubMed ID	wds:Q70409082-E9DA412E-0E8B-43E3-ACEB-76F81041E3B9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6394758
PubMed ID	6394758
published in	wds:Q70409082-9FB45EE0-1DE8-4D12-B5A6-E4F9E72783CE
published in	The Journal of Rheumatology
issue	wds:Q70409082-199ABA7C-7BE3-4624-A42A-E16772D2D858
volume	wds:Q70409082-3E722371-D884-4429-B2B6-624B69BDCB97
issue	6
volume	11
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70409082
is cites work of	Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity Rheumatoid arthritis in the aged. Incidence and optimal management Methotrexate therapy in rheumatoid arthritis. Current status Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis? Methotrexate for treating rheumatoid arthritis Tolerability of methotrexate starting with 15 or 25 mg/week for rheumatoid arthritis Methotrexate in rheumatoid arthritis: a quarter century of development Rational use of disease-modifying antirheumatic drugs Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritis Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis Low-dose methotrexate treatment of rheumatoid arthritis; long-term observation of efficacy and safety New perspectives of secondary and tertiary therapy for rheumatoid arthritis Long-term tolerability of methotrexate at doses exceeding 15 mg per week in rheumatoid arthritis. Life threatening acute pneumonitis during low dose methotrexate treatment for rheumatoid arthritis: a case report and review of the literature Recommendations for the use of methotrexate in juvenile idiopathic arthritis Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis Methotrexate and rheumatoid arthritis Methotrexate in refractory rheumatoid arthritis Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up A clinical and biochemical assessment of methotrexate in rheumatoid arthritis. Intestinal absorption in patients with rheumatoid arthritis treated with methotrexate [Methotrexate therapy in rheumatologic diseases--an update] In rheumatoid arthritis is compliance in physicians more of a problem than compliance in patients? Methotrexate in rheumatology Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs in elderly patients with rheumatoid arthritis Methotrexate intolerance in elderly patients with rheumatoid arthritis: what are the alternatives? Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria Can treatment with methotrexate influence the radiological progression of rheumatoid arthritis? A clinical and economic review of disease-modifying antirheumatic drugs Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first-line disease-modifying agent? Efficacy and Toxicity Profile of Methotrexate Chloroquine Combination in Treatment of Active Rheumatoid Arthritis Experience with low-dose methotrexate: toxicity, tolerability and effect on conventional patterns of drug therapy for inflammatory arthritis Durability of treatment with methotrexate in Venezuelan patients with rheumatoid arthritis Isolated thrombocytopenia associated with low dose methotrexate therapy Pharmacotherapy Pearls in Rheumatology for the Care of Older Adult Patients: Focus on Oral Disease-Modifying Antirheumatic Drugs and the Newest Small Molecule Inhibitors [Methotrexate]
is cites work of	wds:Q54124315-D37D41F5-4E2B-4E7F-8A0E-4A435199CC6D wds:Q52871859-BF58ABCC-4600-49E2-99BA-F3A437B151DA wds:Q72897264-EC61C32E-9C11-4826-9220-6053A4818989 wds:Q73819435-2D3CE072-458D-4CA5-9B1B-0BDB611DC5B8 wds:Q68636706-8D778169-95CE-409A-A0EA-B626A74C4FC4 wds:Q24194047-EAF5BE6D-2E49-4B10-8DDD-080DE5BF99D8 wds:Q37498849-316993BD-B3F5-45CE-9506-A5CDEDEC562F wds:Q38078271-5106E540-D116-42B1-9E99-D77E0E5A6FFA wds:Q43259353-35D01EEC-EFA5-42FE-9F03-8594F9825F47 wds:Q41808826-50EFF733-42AC-4236-99CD-A693EF6EC38A wds:Q69779303-10E333ED-8E94-4E02-8CF4-E6FE5774155A wds:Q68636710-4269DD16-4654-4960-B4AE-B5424C64DFFF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software